Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Dooley

Showing results (351-360 of 370) with videos related to

Pageof 37
Sort By:
Bioorganic & Medicinal Chemistry Letters|August 28, 1999
Structure-activity relationship of N-methyl-N-aralkyl-peptidylamines as novel N-type calcium channel blockersL Y Hu, T R Ryder, M F Rafferty, et al.
Genes & Development|March 8, 2013
The tumor suppressor SirT2 regulates cell cycle progression and genome stability by modulating the mitotic deposition of H4K20 methylationLourdes Serrano, Paloma Martínez-Redondo, Anna Marazuela-Duque, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 24, 2014
Contribution of copy-number variation to Down syndrome-associated atrioventricular septal defectsDhanya Ramachandran, Jennifer G Mulle, Adam E Locke, et al.
Clinical Pharmacokinetics|December 22, 2025
A Pharmacokinetic Analysis of Intravenous Fluconazole in Adult Patients Undergoing Mechanical Circulatory Support Device ImplantationKelly A Cairns, Maria Patricia Hernandez-Mitre, Trisha N Peel, et al.
Birth Defects Research. Part A, Clinical and Molecular Teratology|October 12, 2011
Lack of maternal folic acid supplementation is associated with heart defects in Down syndrome: a report from the National Down Syndrome ProjectLora J H Bean, Emily G Allen, Stuart W Tinker, et al.
Genetic Epidemiology|August 19, 2010
Variation in folate pathway genes contributes to risk of congenital heart defects among individuals with Down syndromeAdam E Locke, Kenneth J Dooley, Stuart W Tinker, et al.
Journal of Medicinal Chemistry|September 23, 2000
(S)-4-Methyl-2-(methylamino)pentanoic acid [4, 4-bis(4-fluorophenyl)butyl]amide hydrochloride, a novel calcium channel antagonist, is efficacious in several animal models of painY Song, S S Bowersox, D T Connor, et al.
G3 (Bethesda, Md.)|July 22, 2015
Genome-Wide Association Study of Down Syndrome-Associated Atrioventricular Septal DefectsDhanya Ramachandran, Zhen Zeng, Adam E Locke, et al.
International Journal of Cardiology|November 22, 2016
Lack of evidence of lower 30-day all-cause readmission in Medicare beneficiaries with heart failure and reduced ejection fraction discharged on spironolactonePhillip H Lam, Daniel J Dooley, Chakradhari Inampudi, et al.
BMJ Open|October 8, 2020
The efficacy and safety of varenicline alone versus in combination with nicotine lozenges for smoking cessation among hospitalised smokers (VANISH): study protocol for a randomised, placebo-controlled trialRukshar Kaizerali Gobarani, Michael J Abramson, Billie Bonevski, et al.
Pageof 37

Showing results (351-360 of 370) with videos related to

Sort By:
Pageof 37
Bioorganic & Medicinal Chemistry Letters|August 28, 1999
Structure-activity relationship of N-methyl-N-aralkyl-peptidylamines as novel N-type calcium channel blockersL Y Hu, T R Ryder, M F Rafferty, et al.
Genes & Development|March 8, 2013
The tumor suppressor SirT2 regulates cell cycle progression and genome stability by modulating the mitotic deposition of H4K20 methylationLourdes Serrano, Paloma Martínez-Redondo, Anna Marazuela-Duque, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 24, 2014
Contribution of copy-number variation to Down syndrome-associated atrioventricular septal defectsDhanya Ramachandran, Jennifer G Mulle, Adam E Locke, et al.
Clinical Pharmacokinetics|December 22, 2025
A Pharmacokinetic Analysis of Intravenous Fluconazole in Adult Patients Undergoing Mechanical Circulatory Support Device ImplantationKelly A Cairns, Maria Patricia Hernandez-Mitre, Trisha N Peel, et al.
Birth Defects Research. Part A, Clinical and Molecular Teratology|October 12, 2011
Lack of maternal folic acid supplementation is associated with heart defects in Down syndrome: a report from the National Down Syndrome ProjectLora J H Bean, Emily G Allen, Stuart W Tinker, et al.
Genetic Epidemiology|August 19, 2010
Variation in folate pathway genes contributes to risk of congenital heart defects among individuals with Down syndromeAdam E Locke, Kenneth J Dooley, Stuart W Tinker, et al.
Journal of Medicinal Chemistry|September 23, 2000
(S)-4-Methyl-2-(methylamino)pentanoic acid [4, 4-bis(4-fluorophenyl)butyl]amide hydrochloride, a novel calcium channel antagonist, is efficacious in several animal models of painY Song, S S Bowersox, D T Connor, et al.
G3 (Bethesda, Md.)|July 22, 2015
Genome-Wide Association Study of Down Syndrome-Associated Atrioventricular Septal DefectsDhanya Ramachandran, Zhen Zeng, Adam E Locke, et al.
International Journal of Cardiology|November 22, 2016
Lack of evidence of lower 30-day all-cause readmission in Medicare beneficiaries with heart failure and reduced ejection fraction discharged on spironolactonePhillip H Lam, Daniel J Dooley, Chakradhari Inampudi, et al.
BMJ Open|October 8, 2020
The efficacy and safety of varenicline alone versus in combination with nicotine lozenges for smoking cessation among hospitalised smokers (VANISH): study protocol for a randomised, placebo-controlled trialRukshar Kaizerali Gobarani, Michael J Abramson, Billie Bonevski, et al.
Pageof 37